Market revenue in 2023 | USD 1,225.6 million |
Market revenue in 2030 | USD 3,410.0 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Bioreactors/fermenters |
Fastest growing segment | Cell Culture Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 31.19% in 2023. Horizon Databook has segmented the France upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
Various companies operating in the upstream bioprocessing market are keen on exploring lucrative opportunities offered by France and are subsequently undertaking initiatives. For instance, in March 2020, BIO-Europe held a conference in Paris to promote the interaction of users, professionals, and commercial bioprocessing equipment manufacturers.
AGC Biologics, a U.S.-based upstream bioprocessing equipment manufacturer, announced its interest in partnering with several local and global manufacturers through this conference.
The company manufactures platforms for process transfer aimed at direct scale-up. In addition, it incorporates a proprietary platform, the CHEF1 expression platform, for optimizing timelines associated with product development. Furthermore, companies in France are supported by receiving grants from various organizations.
Moreover, upstream bioprocessing is an essential step in vaccine development. Hence, this initiative is expected to strengthen the position of Naobios in the upstream bioprocessing market, driving market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the France upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into France upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account